General Information of the Compound
Compound ID
CP0570143
Compound Name
N-[[2-chloro-4-(methanesulfonamido)phenyl]methyl]-4-(2-hydroxypropan-2-yl)benzamide
    Show/Hide
Structure
Formula
C18H21ClN2O4S
Molecular Weight
396.896
Canonical SMILES
CC(C)(O)c1ccc(cc1)C(=O)NCc1ccc(NS(C)(=O)=O)cc1Cl
    Show/Hide
InChI
InChI=1S/C18H21ClN2O4S/c1-18(2,23)14-7-4-12(5-8-14)17(22)20-11-13-6-9-15(10-16(13)19)21-26(3,24)25/h4-10,21,23H,11H2,1-3H3,(H,20,22)
    Show/Hide
InChIKey
MMIXUSJYTSMKEI-UHFFFAOYSA-N
Physicochemical Property
logP
2.8689
Rotatable Bonds
6
Heavy Atom Count
26
Polar Areas
95.5
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
4
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 166629451
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01286, Bile acid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
EC50 = 32 nM
   TI
   LI
   LO
   TS